Endothelial Cell-Derived IL-18 Released During Ischemia Reperfusion Injury Selectively Expands T Peripheral Helper Cells to Promote Alloantibody Production.
Background: Ischemia reperfusion injury (IRI) predisposes to formation of donor specific antibodies (DSA), a factor contributing to chronic rejection and late allograft loss. Methods: We describe a mechanism underlying the correlative association between IRI and DSA using humanized models and patient specimens. Results: IRI induces IgM-dependent complement activation on endothelial cells (ECs) which assembles an NLRP3 inflammasome via a Rab5-ZFYVE21-NIK axis and upregulates ICOS-L and PD-L2. EC-derived IL-18 selectively expands a T cell population (CD4+CD45RO+PD1hiICOS+CCR2+CXCR5-) displaying features of recently described T peripheral helper (TPH) cells. This population highly expressed IL-18R1 and promoted DSA in response to IL-18 in vivo. In patients with delayed graft function (DGF), a clinical manifestation of IRI, these cells were Ki-67+IL-18R1+ and could be expanded ex vivo in response to IL-18. Conclusions: IRI promotes elaboration of IL-18 from ECs to selectively expand alloreactive IL18R1+ TPH cells in allograft tissues to promote DSA formation.